Lv22
200 积分 2022-11-23 加入
Defining clinically useful biomarkers of immune checkpoint inhibitors in solid tumours
1天前
已完结
Circulating tumor DNA clearance as a predictive biomarker of pathologic complete response in patients with solid tumors treated with neoadjuvant immune checkpoint inhibitors: a systematic review and meta-analysis
1个月前
已完结
Biological and clinical significance of tumour-infiltrating lymphocytes in the era of immunotherapy: a multidimensional approach
1个月前
已完结
Programmed death ligand-1 (PD-L1) as a predictive marker for immunotherapy in solid tumours: a guide to immunohistochemistry implementation and interpretation
1个月前
已完结
The impact of concomitant medications on treatment outcomes in patients with cancer receiving immune checkpoint inhibitors
1个月前
已完结
Bioprinted Multicomponent Hydrogel Co-culture Tumor-Immune Model for Assessing and Simulating Tumor-Infiltrated Lymphocyte Migration and Functional Activation
5个月前
已完结
Patient-Derived Organoids from Locally Advanced Gastric Adenocarcinomas Can Predict Resistance to Neoadjuvant Chemotherapy
5个月前
已完结
Generation, Expansion, and Biobanking of Gastrointestinal Patient-Derived Organoids from Tumor and Normal Tissues
5个月前
已完结
Aberrant PJA2-CHRM3 signaling creates a therapeutic vulnerability in gastric tumor
5个月前
已完结
Discovery of Potent and Selective Pyrrolo[2,3-d]Pyrimidine-Based Aurora A Inhibitors with Demonstrated Efficacy against Patient-Derived Gastric Cancer Organoids
5个月前
已完结
皖公网安备34019202002308
